Missed opportunities for DCD kidney donors: Evaluation of warm ischemic time and associated functional warm ischemic time.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
11 2019
Historique:
received: 31 05 2019
revised: 04 09 2019
accepted: 23 09 2019
pubmed: 5 10 2019
medline: 24 9 2020
entrez: 5 10 2019
Statut: ppublish

Résumé

Many transplant centers utilize a hard cutoff of 2 hours of warm ischemic time (WIT), defined as the time from withdrawal of life-sustaining measures to cold organ flush, to exclude donation after circulatory determination of death (DCD) kidney donation. As a result, almost a quarter of withdrawals to retrieve DCD organs fail to produce kidney transplants in Ontario. In order to assess our ability to increase organ yield, we wanted to characterize WIT and functional WIT (fWIT, time from systolic blood pressure <50 mm Hg to cold organ flush), as well as determine the time at which potential donors eventually die in those that did not become organ donors. A retrospective review of all DCD kidney donors in Ontario was performed utilizing the Trillium Gift of Life Database from April 2013 to February 2018. Of 350 DCD kidney donors analyzed, 46.9% had < 0.5 hours, 51.7% between 0.5 and 2 hours, and 1.4% >2 hours of WIT. In each of these categories (WIT <0.5 hours, 0.5-2 hours and >2 hours), the percentage of patients with fWIT <30 minutes was 100%, 94.4%, and 100%, respectively (P = NS). There were 106 potential donors who did not end up donating due to WIT >2 hours. Of these, 20.8% died between 2 and 4 hours, 10.4% between 4 and 6 hours, and 68.8% beyond 6 hours. The percentage of donors with fWIT >30 minutes did not increase with increasing WIT in DCD donors that went on to donate organs. These data support assessment of waiting up to 4 hours for DCD kidney donation as long as fWIT remains low.

Identifiants

pubmed: 31585486
doi: 10.1111/ctr.13724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13724

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Neyrinck A, Van Raemdonck D, Monbaliu D. Donation after circulatory death: current status. Curr Opin Anaesthesiol. 2013;26:382-390.
Rao V, Dhanani S, Maclean J, et al. Effect of organ donation after circulatory determination of death on number of organ transplants from donors with neurologic determination of death. CMAJ. 2017;189:E1206-E1211.
NorrisS. Organ donation and transplantation in Canada highlights. Parliam Inf Res Serv. 2015;459-460. Publication number is 2018-13-E.
Trillium Gift of Life Network. Ontario's referral and listing criteria for adult kidney transplantation. 1-4.
Scalea JR, Redfield RR, Arpali E, et al. Does DCD donor time-to-death affect recipient outcomes? Implications of time-to-death at a high-volume center in the united states. Am J Transplant. 2017;17:191-200.
Reid A, Harper S, Jackson CH, et al. Expansion of the kidney donor pool by using cardiac death donors with prolonged time to cardiorespiratory arrest. Am J Transplant. 2011;11:995-1005.
Manara AR, Murphy PG, Ocallaghan G. Donation after circulatory death. Br J Anaesth. 2012;108:i108-i121.
Novick AC. Renal hypothermia: in vivo and ex vivo. Urol Clin North Am. 1983;10:637-644.
Porpiglia F, Renard J, Billia M, et al. Is renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible? one-year results of a prospective study. Eur Urol. 2007;52:1170-1178.
Volpe A, Blute ML, Ficarra V, et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol. 2015;68(1):61-74.
Alina I.Annual Statistics on Organ Replacement in Canada; 2017. https://secure.cihi.ca/free_products/CORR-snapshot-en-web.pdf. Accessed May 20, 2018.
Canadian Institute for Health Information. Statistics on Organ Transplants, Waiting Lists and Donors; 2016. https://www.cihi.ca/en/e-statistics-on-organ-transplants-waiting-lists-and-donors. Accessed May 23, 2018.
Suntharalingam C, Sharples L, Dudley C, et al. Time to cardiac death after withdrawal of life-sustaining treatment in potential organ donors. Am J Transplant. 2009;9:2157-2165.
Russell JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation - a prospective study. Transplantation. 1992;54:656-660.
Oniscu GC. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol. 2005;16:1859-1865.
Bellingham JM, Santhanakrishnan C, Neidlinger N, et al. Donation after cardiac death: a 29-year experience. Surgery. 2012;150:692-702.
Chan E, Boyle SL, Campbell J, et al. Ipsilateral renal function preservation following minimally invasive partial nephrectomy: the effect of tumour characteristics and warm ischemic time. Can Urol Assoc J. 2017;11(10):344-349.
Bradley JA, Pettigrew GJ, Watson CJ. Time to death after withdrawal of treatment in donation after circulatory death (DCD) donors. Curr Opin Organ Transplant. 2013;18:133-139.

Auteurs

Jeffrey Law (J)

Department of Surgery (Urology), Western University, London, Ontario, Canada.
Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Karen Hornby (K)

Trillium Gift of Life Network, Toronto, Ontario, Canada.

Clare Payne (C)

Trillium Gift of Life Network, Toronto, Ontario, Canada.

Alp Sener (A)

Department of Surgery (Urology), Western University, London, Ontario, Canada.
Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Multiorgan Transplant Program, Western University, London, Ontario, Canada.

Patrick P Luke (PP)

Department of Surgery (Urology), Western University, London, Ontario, Canada.
Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Multiorgan Transplant Program, Western University, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH